From: Clinical applications of artificial intelligence and radiomics in neuro-oncology imaging
I—Gliomas |
I—Differentiation of neoplastic from non-neoplastic lesions |
 High-grade gliomas versus tumefactive demyelinating diseases |
 Gliomas versus inflammation |
II—Grading of gliomas |
 Low versus high grade |
 Grade II versus grade III |
III—Radiogenomics |
 Glioma |
 Oligodendroglioma |
IV—Pre-treatment evaluation |
 Tumor segmentation |
 Infiltration and extent |
V—Prognostic value-survival |
VI—Post-treatment evaluation |
 Pseudo-progression |
 Residual/recurrence versus post-treatment changes |
II—Non glioma |
Metastasis |
PCNSL |
Hemangioblastoma |
III—Extra-axial brain tumors |
Meningioma |
Schwannoma |
Pituitary adenoma |
IV—Pediatric brain tumors |
Characterization |
Radiogenomics |